Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Scientific Energy (SCGY) Cash & Equivalents (2016 - 2025)

Scientific Energy filings provide 11 years of Cash & Equivalents readings, the most recent being $5.8 million for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 14.72% to $5.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.8 million, a 14.72% decrease, with the full-year FY2024 number at $4.9 million, up 55.3% from a year prior.
  • Cash & Equivalents hit $5.8 million in Q3 2025 for Scientific Energy, down from $6.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $6.8 million in Q3 2024 to a low of $20983.0 in Q1 2021.
  • Median Cash & Equivalents over the past 5 years was $3.2 million (2023), compared with a mean of $3.6 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 33908.67% in 2021 and later plummeted 72.04% in 2023.
  • Scientific Energy's Cash & Equivalents stood at $4.9 million in 2021, then tumbled by 45.58% to $2.7 million in 2022, then grew by 18.18% to $3.2 million in 2023, then soared by 55.3% to $4.9 million in 2024, then rose by 17.93% to $5.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.8 million (Q3 2025), $6.5 million (Q2 2025), and $5.7 million (Q1 2025) per Business Quant data.